Skip to main content

ORIGINAL RESEARCH article

Front. Genet.

Sec. Human and Medical Genomics

Volume 16 - 2025 | doi: 10.3389/fgene.2025.1564824

This article is part of the Research Topic Advances in molecular genetics of Marfan syndrome and related disorders View all articles

Functional analysis of a novel FBN1 deep intronic variant causing Marfan syndrome in a Chinese patient

Provisionally accepted
Qingming Wang Qingming Wang 1fang Zhang fang Zhang 1Xinlong Zhou Xinlong Zhou 1Hui Li Hui Li 2Juan Zhao Juan Zhao 2Haiming Yuan Haiming Yuan 1*
  • 1 Dongguan Maternal and Child Health Hospital, Guangdong, China
  • 2 Huadu District People’s Hospital, Southern Medical University, Guangzhou, China

The final, formatted version of the article will be published soon.

    Marfan syndrome (MFS MIM#154700), due to pathogenic variants in the FBN1 gene, is an autosomal dominant connective tissue disorder, typically involving the skeletal, cardiovascular and ocular systems. Currently, over 3000 MFS patients were reported, and approximately 1800 pathogenic variants in FBN1 were identified. However, the molecular diagnosis still remains challenging for 8-10% of patients with clinical features suggestive of MFS. In this study, we reported a 2-month-old Chinese female patient whose clinical features were compatible with the MFS. Whole-exome sequencing (WES) identified a novel de novo deep intronic variant, c.4943-8_4943-7insTATGTGATATTCAT TCAC in intron 40 of FBN1 that was predicted to affect the RNA splicing. Minigene analysis showed that this variant causes skipping of exon 41, leading to the deletion of 41 amino acids (c.4943_5065del, p.Val1649_Asp1689del). It confirmed the pathogenic nature of the variant and established the genotype-phenotype relationship. Our study expands the mutation spectrum of FBN1 and emphasizes the importance of deep intronic variant interpretation and the need for additional functional studies to verify the pathogenicity of these variants.

    Keywords: deep intronic variant, FBN1, Marfan Syndrome, Minigene, RNA Splicing

    Received: 22 Jan 2025; Accepted: 28 Feb 2025.

    Copyright: © 2025 Wang, Zhang, Zhou, Li, Zhao and Yuan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Haiming Yuan, Dongguan Maternal and Child Health Hospital, Guangdong, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

    Research integrity at Frontiers

    Man ultramarathon runner in the mountains he trains at sunset

    94% of researchers rate our articles as excellent or good

    Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


    Find out more